Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Aimmune Therap (AIMT)

Aimmune Therap (AIMT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Aimmune Therap 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005 USA

P: 650-614-5220 F: 650-616-0075

Description:

Aimmune Therapeutics, Inc. is a biopharmaceutical company which is engaged in the development of desensitization treatments for peanut and other food allergies. The Company's characterized oral desensitization immunotherapy includes AR101, a product for the treatment of peanut allergy in children and adults which is in clinical trial stage. Aimmune Therapeutics, Inc. is headquartered in Brisbane, California.

Key Statistics

Overview:

Market Capitalization, $K 1,979,714
Shares Outstanding, K 62,669
Annual Sales, $ 0 K
Annual Net Income, $ -210,750 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -64,460 K
60-Month Beta -0.03
% of Insider Shareholders 13.75%
% of Institutional Shareholders 82.31%
Float, K 54,052
% Float 86.25%

Growth:

1-Year Return 38.43%
3-Year Return 42.81%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.03 on 11/06/19
Next Earnings Date N/A
Earnings Per Share ttm -3.86
EPS Growth vs. Prev Qtr -1.98%
EPS Growth vs. Prev Year -15.73%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

AIMT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -7.16
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -104.54
Return-on-Assets (Before Tax) -77.54
Profit Margin % N/A
Net Margin % N/A
Debt/Equity 0.24
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 12.64
Book Value/Share 2.44
Interest Coverage N/A
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar